Literature DB >> 22279123

Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

Chahnaz Kebaier1, Robin R Chamberland, Irving C Allen, Xi Gao, Peter M Broglie, Joshua D Hall, Corey Jania, Claire M Doerschuk, Stephen L Tilley, Joseph A Duncan.   

Abstract

Staphylococcus aureus is a dangerous pathogen that can cause necrotizing infections characterized by massive inflammatory responses and tissue destruction. Staphylococcal α-hemolysin is an essential virulence factor in severe S. aureus pneumonia. It activates the nucleotide-binding domain and leucine-rich repeat containing gene family, pyrin domain containing 3 (NLRP3) inflammasome to induce production of interleukin-1β and programmed necrotic cell death. We sought to determine the role of α-hemolysin-mediated activation of NLRP3 in the pathogenesis of S. aureus pneumonia. We show that α-hemolysin activates the NLRP3 inflammasome during S. aureus pneumonia, inducing necrotic pulmonary injury. Moreover, Nlrp3(-/-) mice have less-severe pneumonia. Pulmonary injury induced by isolated α-hemolysin or live S. aureus is independent of interleukin-1β signaling, implicating NLRP3-induced necrosis in the pathogenesis of severe infection. This work demonstrates the exploitation of host inflammatory signaling by S. aureus and suggests the NLRP3 inflammasome as a potential target for pharmacologic interventions in severe S. aureus infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22279123      PMCID: PMC3274379          DOI: 10.1093/infdis/jir846

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Taeok Bae; Michael Otto; Frank R Deleo; Olaf Schneewind
Journal:  Nat Med       Date:  2007-12       Impact factor: 53.440

2.  Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

Authors:  Hal M Hoffman; Martin L Throne; N J Amar; Mohamed Sebai; Alan J Kivitz; Arthur Kavanaugh; Steven P Weinstein; Pavel Belomestnov; George D Yancopoulos; Neil Stahl; Scott J Mellis
Journal:  Arthritis Rheum       Date:  2008-08

Review 3.  The role of virulence determinants in community-associated MRSA pathogenesis.

Authors:  Binh An Diep; Michael Otto
Journal:  Trends Microbiol       Date:  2008-06-26       Impact factor: 17.079

4.  A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome.

Authors:  Raúl Muñoz-Planillo; Luigi Franchi; Lloyd S Miller; Gabriel Núñez
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

5.  Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia.

Authors:  Brook E Ragle; Juliane Bubeck Wardenburg
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

6.  Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients.

Authors:  Megumu Saito; Ryuta Nishikomori; Naotomo Kambe; Akihiro Fujisawa; Hideaki Tanizaki; Kyoko Takeichi; Tomoyuki Imagawa; Tomoko Iehara; Hidetoshi Takada; Tadashi Matsubayashi; Hiroshi Tanaka; Hisashi Kawashima; Kiyoshi Kawakami; Shinji Kagami; Ikuo Okafuji; Takakazu Yoshioka; Souichi Adachi; Toshio Heike; Yoshiki Miyachi; Tatsutoshi Nakahata
Journal:  Blood       Date:  2007-12-06       Impact factor: 22.113

7.  Critical role of NOD2 in regulating the immune response to Staphylococcus aureus.

Authors:  Hitesh S Deshmukh; James B Hamburger; Sun Hee Ahn; Dewey G McCafferty; Suxiao R Yang; Vance G Fowler
Journal:  Infect Immun       Date:  2009-01-12       Impact factor: 3.441

8.  NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation.

Authors:  Petr Hruz; Annelies S Zinkernagel; Gabriela Jenikova; Gregory J Botwin; Jean-Pierre Hugot; Michael Karin; Victor Nizet; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

9.  Glyburide inhibits the Cryopyrin/Nalp3 inflammasome.

Authors:  Mohamed Lamkanfi; James L Mueller; Alberto C Vitari; Shahram Misaghi; Anna Fedorova; Kurt Deshayes; Wyne P Lee; Hal M Hoffman; Vishva M Dixit
Journal:  J Cell Biol       Date:  2009-10-05       Impact factor: 10.539

10.  Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.

Authors:  Robin R Craven; Xi Gao; Irving C Allen; Denis Gris; Juliane Bubeck Wardenburg; Erin McElvania-Tekippe; Jenny P Ting; Joseph A Duncan
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more
  123 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  The impact of α-toxin on host cell plasma membrane permeability and cytokine expression during human blood infection by CA-MRSA USA300.

Authors:  Tyler K Nygaard; Kyler B Pallister; Oliwia W Zurek; Jovanka M Voyich
Journal:  J Leukoc Biol       Date:  2013-09-11       Impact factor: 4.962

3.  Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice.

Authors:  Roger V Ortines; Haiyun Liu; Lily I Cheng; Taylor S Cohen; Heather Lawlor; Abhishek Gami; Yu Wang; Carly A Dillen; Nathan K Archer; Robert J Miller; Alyssa G Ashbaugh; Bret L Pinsker; Mark C Marchitto; Christine Tkaczyk; C Kendall Stover; Bret R Sellman; Lloyd S Miller
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 4.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 5.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

Review 6.  The NLRP6 inflammasome in health and disease.

Authors:  Laxman Ghimire; Sagar Paudel; Liliang Jin; Samithamby Jeyaseelan
Journal:  Mucosal Immunol       Date:  2020-01-27       Impact factor: 7.313

7.  Orchestration of human macrophage NLRP3 inflammasome activation by Staphylococcus aureus extracellular vesicles.

Authors:  Xiaogang Wang; William J Eagen; Jean C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-27       Impact factor: 11.205

8.  Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy.

Authors:  Cecilia F Volk; Sarah Burgdorf; Graham Edwardson; Victor Nizet; George Sakoulas; Warren E Rose
Journal:  Clin Infect Dis       Date:  2020-06-10       Impact factor: 9.079

9.  A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome.

Authors:  Anukriti Mathur; Shouya Feng; Jenni A Hayward; Chinh Ngo; Daniel Fox; Ines I Atmosukarto; Jason D Price; Kristina Schauer; Erwin Märtlbauer; Avril A B Robertson; Gaetan Burgio; Edward M Fox; Stephen H Leppla; Nadeem O Kaakoush; Si Ming Man
Journal:  Nat Microbiol       Date:  2018-12-10       Impact factor: 17.745

Review 10.  Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.

Authors:  Vigyasa Singh; Ujjal Jyoti Phukan
Journal:  Med Microbiol Immunol       Date:  2018-11-27       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.